GlassScriptPhysician profile
Amy Anne Barko
NPI 1316263718
$4,391.84
in general payments reported to CMS, 2019-2025
30 companies · $1,563 in 2025
The $1,563 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $240 · 2021: $146 · 2022: $387 · 2023: $903 · 2024: $761 · 2025: $1,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,226 · Travel and Lodging: $859 · Consulting Fee: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,225.85 |
| Travel and Lodging | $858.77 |
| Consulting Fee | $142.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,171.32 | 2025 | |
| Convatec INC. | $761.75 | 2023-2024 | |
| Smith+Nephew, INC. | $344.71 | 2019-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Next Science LLC | $292.59 | 2024-2025 | Blastx, Xperience, Surgx |
| Cardiovascular Systems INC. | $207.84 | 2019 | |
| Medtronic Vascular, INC. | $153.39 | 2020 | |
| Bioventus LLC | $142.60 | 2024 | Exogen Ultrasound Bone Healing System |
| Access Pro Medical, LLC | $134.16 | 2025 | Matriderm |
| Wright Medical Technology, INC. | $124.44 | 2019-2020 | |
| Polymedics Innovations INC. | $116.07 | 2023 | |
| Melinta Therapeutics, LLC | $111.30 | 2019-2023 | Orbactiv, Kimyrsa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $93.49 | 2020-2024 | Jublia |
| Paratek Pharmaceuticals, INC. | $86.23 | 2021-2023 | Nuzyra |
| In2bones USA, LLC | $83.22 | 2022 | |
| Nevro Corp. | $79.77 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $63.59 | 2019-2023 | Hymovis |
| Pacira Pharmaceuticals Incorporated | $62.60 | 2023-2025 | Zilretta, Exparel, Iovera |
| Boston Scientific Corporation | $52.46 | 2021 | |
| Kerecis Limited | $44.08 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Epsfl, LLC | $43.30 | 2023 | |
| Heron Therapeutics, INC. | $36.76 | 2024 | Zynrelef |
| Kowa Pharmaceuticals America, INC. | $36.45 | 2023 | Seglentis |
| Argentum Medical | $27.19 | 2023 | |
| Depuy Synthes Sales INC. | $21.74 | 2024 | Minibunion |
| Organogenesis INC. | $21.11 | 2022 | |
| Kci USA, INC. | $18.78 | 2020 | |
| Legacy Ortho LLC | $17.53 | 2023 | |
| Bone Support INC. | $16.59 | 2025 | Ceramentbone Void Filler, Cerament G |
| Reprise Biomedical, INC. | $14.19 | 2024 | Miro3d |
| Horizon Therapeutics Plc | $12.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Barko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.